Encapsulation of a proteasome inhibitor with gold-polysaccharide nanocarriers
Source abstract
Abstract
Organic-inorganic hybrid nanoparticles are potential effective systems for drug delivery in cancer therapy and diagnosis. Chitosan-gum arabic with entrapped gold nanoparticles were developed as a carrier for an anticancer drug bortezomib. The nanosystem was designed to enhance the proteasome inhibitor activity in pancreatic cell lines, S2-013 and hTERT-HPNE. The hydrodynamic diameter of chitosan-gum arabic-gold nanoparticles loaded with bortezomib is around 330 nm. Laser scanning confocal microscopy images show the uptake of the gold nanoparticle/bortezomib encapsulated in chitosan-gum arabic matrix and the fast internalization of these nano combinations into pancreatic cells. Cytotoxic assays assessed that positively charged nanosystems reduce the cell growth and cell proliferation of S2-013s, but the same effect was not observed in cytotoxic response in hTERT-HPNE cells. The outcomes of this study demonstrate the capacity of chitosan-gum arabic nanocarriers to deliver gold nanoparticles/anticancer drug and to increase the permeation and retention effect in S2-013 cells and minimize drug side effects in HPNE cells. © 2014 Springer Science+Business Media.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Ubiquitin and proteasome pathways · Peptidase Inhibition and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Alvarez-Lorenzo C, Blanco-Fernandez B, Puga AM, Concheiro A (2013) Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery. Adv Drug Deliv Rev 65(9):1148–117110.1016/j.addr.2013.04.016 ↗
2. Avadi MR, Sadeghi AMM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, Rafiee-Tehrani M (2010) Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomed Nanotechnol Biol Med 6(1):58–6310.1016/j.nano.2009.04.007 ↗
3. Avadi MR, Sadeghi AMM, Mohamadpour Dounighi N, Dinarvand R, Atyabi F, Rafiee-Tehrani M (2011) Ex vivo evaluation of insulin nanoparticles using chitosan and arabic gum. ISRN Pharm 2011:6
4. Baptista P, Doria G, Henriques D, Pereira E, Franco R (2005) Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles. J Biotechnol 119(2):111–11710.1016/j.jbiotec.2005.02.019 ↗
5. Beija M, Salvayre R, Lauth-de Viguerie N, Marty JD (2012) Colloidal systems for drug delivery: from design to therapy. Trends Biotechnol 30(9):485–49610.1016/j.tibtech.2012.04.008 ↗
6. Choi S, Jang S, Park J, Jeong S, Park J, Ock K, Lee K, Yang S, Joo S-W, Ryu P, Lee S (2012) Cellular uptake and cytotoxicity of positively charged chitosan gold nanoparticles in human lung adenocarcinoma cells. J Nanopart Res 14(12):1–13. doi: 10.1007/s11051-012-1234-510.1007/s11051-012-1234-5 ↗
7. Coelho S, Moreno-Flores S, Toca-Herrera JL, Coelho MA, Pereira MC, Rocha S (2011) Nanostructure of polysaccharide complexes. J Colloid Interface Sci 363(2):450–45510.1016/j.jcis.2011.07.098 ↗
8. Coelho SC, Rocha S, Juzenas P, Sampaio P, Almeida GM, Silva FS, Pereira MC, Coelho MA (2013) Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells. Expert Opin Drug Deliv 10(10):1345–135210.1517/17425247.2013.827659 ↗
9. Coelho SC, Rocha S, Pereira MC, Juzenas P, Coelho MAN (2014) Enhancing proteasome-inhibitor effect by functionalized gold nanoparticles. J Biomed Nanotechnol 10(4):717–723. doi: 10.1166/jbn.2014.174310.1166/jbn.2014.1743 ↗
10. Duncan B, Kim C, Rotello VM (2010) Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release 148(1):122–127. doi: 10.1016/j.jconrel.2010.06.00410.1016/j.jconrel.2010.06.004 ↗
11. Garnett MC, Kallinteri P (2006) Nanomedicines and nanotoxicology: some physiological principles. Occup Med 56(5):307–311. doi: 10.1093/occmed/kql05210.1093/occmed/kql052 ↗
12. Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307–1315. doi: 10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
13. Gomes JF, Rocha S, do Carmo Pereira M, Peres I, Moreno S, Toca-Herrera J, Coelho MA (2010) Lipid/particle assemblies based on maltodextrin-gum arabic core as bio-carriers. Colloids Surf B 76(2):449–45510.1016/j.colsurfb.2009.12.004 ↗
14. Goodarzi N, Varshochian R, Kamalinia G, Atyabi F, Dinarvand R (2013) A review of polysaccharide cytotoxic drug conjugates for cancer therapy. Carbohydr Polym 92(2):1280–129310.1016/j.carbpol.2012.10.036 ↗
15. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105(33):11613–11618. doi: 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
16. Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155(3):344–35710.1016/j.jconrel.2011.06.004 ↗
17. Iwamura T, Taniguchi S, Kitamura N, Yamanari H, Kojima A, Hidaka K, Setoguchi T, Katsuki T (1992) Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2). J Gastroenterol Hepatol 7(5):512–51910.1111/j.1440-1746.1992.tb01030.x ↗
18. Iyer AK, Khaled G, Fang J, Maeda H (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11(17–18):812–81810.1016/j.drudis.2006.07.005 ↗
19. Joo C, Zhan C, Li Q, Yazdanfar S (2010) Autoconfocal transmission microscopy based on two-photon-induced photocurrent of Si photodiodes. Opt Lett 35(1):67–6910.1364/OL.35.000067 ↗
20. Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS (2010) Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 5(6):465–47210.1038/nnano.2010.58 ↗
21. Lee KM, Nguyen C, Ulrich AB, Pour PM, Ouellette MM (2003) Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem Biophys Res Commun 301(4):1038–104410.1016/S0006-291X(03)00086-X ↗
22. Lee J, Twomey M, Machado C, Gomez G, Doshi M, Gesquiere AJ, Moon JH (2013) Caveolae-mediated endocytosis of conjugated polymer nanoparticles. Macromol Biosci 13(7):913–92010.1002/mabi.201300030 ↗
23. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60(15):1650–1662. doi: 10.1016/j.addr.2008.09.00110.1016/j.addr.2008.09.001 ↗
24. Liu J, Xu L, Liu C, Zhang D, Wang S, Deng Z, Lou W, Xu H, Bai Q, Ma J (2012) Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohydr Polym 90(1):16–22. doi: 10.1016/j.carbpol.2012.04.03610.1016/j.carbpol.2012.04.036 ↗
25. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A et al (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83(11):757–76610.1093/jnci/83.11.757 ↗
26. Moschakis T, Murray BS, Biliaderis CG (2010) Modifications in stability and structure of whey protein-coated o/w emulsions by interacting chitosan and gum arabic mixed dispersions. Food Hydrocoll 24(1):8–17. doi: 10.1016/j.foodhyd.2009.07.00110.1016/j.foodhyd.2009.07.001 ↗
27. Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, Kim Y, Park JH, Kim J, Her S, Oh YK, Kwon IC, Kim K, Jeong SY (2009) Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 135(3):259–26710.1016/j.jconrel.2009.01.018 ↗
28. Nitta S, Numata K (2013) Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci 14(1):1629–165410.3390/ijms14011629 ↗
29. Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8(2):147–16610.1016/j.nano.2011.05.016 ↗
30. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P (2010) Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 62(3):346–361. doi: 10.1016/j.addr.2009.11.00710.1016/j.addr.2009.11.007 ↗
31. Peres I, Rocha S, Loureiro J, Carmo Pereira M, Ivanova G, Coelho M (2012) Carbohydrate particles as protein carriers and scaffolds: physico-chemical characterization and collagen stability. J Nanopart Res 14(9):1–11. doi: 10.1007/s11051-012-1144-610.1007/s11051-012-1144-6 ↗
32. Ruíz-Ramos JO, Pérez-Orozco JP, Báez-González JG, Bósquez-Molina E, Pérez-Alonso C, Vernon-Carter EJ (2006) Interrelationship between the viscoelastic properties and effective moisture diffusivity of emulsions with the water vapor permeability of edible films stabilized by mesquite gum–chitosan complexes. Carbohydr Polym 64(2):355–363. doi: 10.1016/j.carbpol.2005.12.02010.1016/j.carbpol.2005.12.020 ↗
33. Shahshahan MA, Beckley MN, Jazirehi AR (2011) Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects. Am J Cancer Res 1(7):913–924
34. Sinha R, Kim GJ, Nie S, Shin DM (2006) Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5(8):1909–1917. doi: 10.1158/1535-7163.mct-06-014110.1158/1535-7163.MCT-06-0141 ↗
35. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82(13):1107–1112. doi: 10.1093/jnci/82.13.110710.1093/jnci/82.13.1107 ↗
36. Taylor U, Klein S, Petersen S, Kues W, Barcikowski S, Rath D (2010) Nonendosomal cellular uptake of ligand-free, positively charged gold nanoparticles. Cytometry A 77(5):439–44610.1002/cyto.a.20846 ↗
37. Tsutsumida H, Swanson BJ, Singh PK, Caffrey TC, Kitajima S, Goto M, Yonezawa S, Hollingsworth MA (2006) RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res 12(10):2976–2987. doi: 10.1158/1078-0432.ccr-05-119710.1158/1078-0432.CCR-05-1197 ↗
38. Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1(3):1112–111610.1038/nprot.2006.179 ↗
39. Wang X, Chi N, Tang X (2008) Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 70(3):735–74010.1016/j.ejpb.2008.07.005 ↗
40. Yousefpour P, Atyabi F, Vasheghani-Farahani E, Movahedi AA, Dinarvand R (2011) Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int J Nanomed 6:1977–1990